Evolving microbes and re-emerging streptococcal disease

Clinics in Laboratory Medicine

Volumn 22, Issue 4, 2002, Pages 835-848

  Krause, Richard M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL GENETICS; BACTERIAL VIRULENCE; EPIDEMIC; EVOLUTION; HOST PARASITE INTERACTION; HUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATIC FEVER; SCARLET FEVER; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; TOXIC SHOCK SYNDROME; UNITED STATES; ACUTE DISEASE; GENETICS; IMMUNOLOGY; PHARYNGITIS; STREPTOCOCCUS PYOGENES;

STREPTOCOCCUS VACCINE;

ACUTE DISEASE; HUMANS; PHARYNGITIS; RHEUMATIC FEVER; SCARLET FEVER; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS PYOGENES;

EID: 0036891957     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-2712(02)00027-6     Document Type: Review

References (29)

1. Krause RM, editor. Emerging Infections. New York: Academic Press; 1998.
2. Wilson GS, Miles AA. Topley and Wilson's Principles of Bacteriology and Immunity. 3rd Edition. Baltimore: Williams & Wilkins; 1946. p. 288.
3. Burnet FM, Lush D. Induced lysogenicity and mutation of bacteriophage within lysogenic bacteria. Aust J Exp Biol Med Sci 1936;14:27-38.
4. Lederberg J. Infectious agents, hosts in constant flux. ASM News 1998;64:18-22.
5. Ross R. The Prevention of Malaria (With Addendum on the Theory of Happenings). London: Murray; 1911.
6. Musser JM, Krause RM. The revival of group A streptococcal diseases, with a commentary on staphylococcal toxic shock syndrome. In: Krause RM, editor. Emerging Infections. New York: Academic Press; 1998. p. 185-218.
7. Katz SL, Morens DM. Severe streptococcal infections in historical perspective. Clin Infect Dis 1992;14:298-307.
8. Quinn RW. Streptococcal infections. In: Evans AS, Feldman HA, editors. Bacterial Infections of Humans: Epidemiology and Control. New York: Plenum Medical; 1982. p. 525-52.
9. Dingle JH, Badger GF, Jordan Jr WS. Illness in the Home: A study of 25,000 Illnesses in a Group of Cleveland Families. Cleveland: The Press of Western Reserve University; 1964. p. 97-128.
10. El Kholy A, Sorour AH, Houser HB, et al. A three-year prospective study of streptococcal infections in a population of rural Egyptian school children. J Med Microbiol 1973;6:101-10.
11. Denny FW, Wannamaker LW, Brink WR, et al. Prevention of rheumatic fever. Treatment of the preceding streptococcic infection. JAMA 1950;143:151-3.
12. Wannamaker LW. The epidemiology of streptococcal infections. In: McCarty M, editor. Streptococcal Infections. New York: Columbia University Press; 1954. p. 157-75.
13. Scott HH. Some Notable Epidemics. London: Edward Arnold & Company; 1934.
14. Corner GW. A History of the Rockefeller Institute, 1901-1953: Origins and Growth. New York: The Rockefeller Institute Press; 1964. p. 47.
15. Low DE, Schwartz B, McGeer A. The reemergence of severe group A streptococcal disease: An evolutionary perspective. In: Scheld WM, Armstrong D, Hughes JM, editors. Emerging Infections. Washington (DC): ASM Press; 1998. p. 93-123.
16. Topley WWC, Wilson GS. The Principles of Bacteriology and Immunity. 1st Edition. London: Edward Arnold & Company; 1929. p. 958-9.
17. Topley WWC, Wilson GS. The Principles of Bacteriology and Immunity. 2nd Edition. London: Edward Arnold & Company; 1936. p. 1167-8.
18. Kaul R, McGeer A, Norrby-Teglund MK, et al. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome - A comparative observational study. Clin Infect Dis 1999;28:800-7.
19. Stollerman GH. The epidemiology of primary and secondary rheumatic fever. In: Uhr JW, editor. The Streptococcus, Rheumatic Fever and Glomerulonephritis. Baltimore: Williams & Wilkins; 1964. p. 311-29.
20. Denny Jr FW. A 45-year perspective on the streptococcus and rheumatic fever: The Edward Kass lecture in infectious disease history. Clin Infect Dis 1994;19:1110-22.
21. Veasy LG, Tani LY, Hill HR. Persistence of acute rheumatic fever in the intermountain area of the United States. J Pediatr 1994;124:9-16.
22. Fischetti VA. Protection against group A streptococcal infection. In: Stevens DL, Kaplan EL, editors. Streptococcal Infections: Clinical Aspects, Microbiology, and Molecular Pathogenesis. New York: Oxford University Press; 2000. p. 371-89.
23. Dale JB. Multivalent group A streptococcal vaccines. In: Stevens DL, Kaplan EL, editors. Streptococcal Infections: Clinical Aspects, Microbiology, and Molecular Pathogenesis. New York: Oxford University Press; 2000. p. 390-401.
24. Michaud C, Trejo-Gutierrez J, Cruz C, et al. Rheumatic heart disease. In: Jamison DT, Mosley WH, Measham AR, et al, editors. Disease Control Priorities in Developing Countries. New York: Oxford University Press; 1993. p. 221-32.
25. Centers for Disease Control and Prevention (US). Addressing Emerging Infectious Disease Threats: A Prevention Strategy for the United States. Atlanta: US Department of Health and Human Services, Public Health Service; 1994.
26. National Institute of Allergy and Infectious Diseases (US). Report of the Task Force on Microbiology and Infectious Diseases. National Institutes of Health, Publication no. 92-3320. Bethesda (MD): US Department of Health and Human Services, Public Health Service; 1992.
27. Institute of Medicine (US). Emerging Infections: Microbial Threats to Health in the United States. Washington (DC): National Academy Press; 1992.
28. Anderson RM. Analytical therapy of epidemics. In: Krause RM, editor. Emerging Infections. New York: Academic Press; 1998. p. 23-50.
29. Anderson RM, May RM. Infectious Diseases of Humans - Dynamics and Control. Oxford: Oxford University Press; 1991.